BioPharm International, June 2010 Issue (PDF)
Optimize Processes by Using CoGs Modeling
Manufacturers, FDA Seek to Secure Supply Chains
International outsourcing and rising theft spur regulatory action and manufacturer oversight.
The Effect of Thermal Cycling on Clamp-Type Fittings
How to control compressive loads on seal materials.
Five Things Every Biotech Company Must Know About Biosimilars
The new US legislation will forever alter the commercial landscape for biologics.
Large-Scale Freezing of Biologics: Understanding Protein and Solute Concentration Changes in a Cryovessel—Part I
Out of Nowhere: Do You Need to Prepare for Highly Improbable Situations?
Being open to unforseen events may avert risk or create opportunities.
The New Normal
New R&D models must be tried, but it will take time to see if they work. In the meantime, a new kind of threat is on the horizon: biobetters.
Biopharmaceutical Facility Cleaning Validation Using the Total Organic Carbon Test
Case studies show TOC is effective for cleaning validation.
Will Protein A Be the Long-Term Solution for Your Purification Needs?
Biomanufacturers and vendors are now exploring more cost-effective purification technologies.
Cost of Goods Modeling and Quality by Design for Developing Cost-Effective Processes
Combine cost analyses with QbD to improve operations and lower costs.